20
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Computerized measurement of LDL particle size in human serum: Reproducibility studies and evaluation of LDL particle size in relation to metabolic variables and the occurrence of atherosclerosis

, , , , , & show all
Pages 649-661 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Björn Fagerberg, Carl Johan Behre, John Wikstrand, Lillemor Mattsson Hultén & Johannes Hulthe. (2008) C‐reactive protein and tumor necrosis factor‐alpha in relation to insulin‐mediated glucose uptake, smoking and atherosclerosis. Scandinavian Journal of Clinical and Laboratory Investigation 68:7, pages 534-541.
Read now

Articles from other publishers (19)

Caroline Schmidt & Göran Bergström. (2013) Apolipoprotein B/Apolipoprotein A-I Ratio and Apolipoprotein B. Angiology 65:10, pages 901-905.
Crossref
Marcus Ståhlman, Björn Fagerberg, Martin Adiels, Kim Ekroos, John M. Chapman, Anatol Kontush & Jan Borén. (2013) Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: Impact on small HDL particles. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1831:11, pages 1609-1617.
Crossref
M. Ståhlman, H. T. Pham, M. Adiels, T. W. Mitchell, S. J. Blanksby, B. Fagerberg, K. Ekroos & J. Borén. (2012) Clinical dyslipidaemia is associated with changes in the lipid composition and inflammatory properties of apolipoprotein-B-containing lipoproteins from women with type 2 diabetes. Diabetologia 55:4, pages 1156-1166.
Crossref
C. Schmidt & J. Wikstrand. (2009) High apoB/apoA-I ratio is associated with increased progression rate of carotid artery intima-media thickness in clinically healthy 58-year-old men: Experiences from very long-term follow-up in the AIR study. Atherosclerosis 205:1, pages 284-289.
Crossref
C. Pettersson, L. Fogelstrand, B. Rosengren, S. Ståhlman, E. Hurt‐Camejo, B. Fagerberg & O. Wiklund. (2008) Increased lipolysis by secretory phospholipase A 2 group V of lipoproteins in diabetic dyslipidaemia . Journal of Internal Medicine 264:2, pages 155-165.
Crossref
M. Rizzo & K. Berneis. (2007) Who needs to care about small, dense low-density lipoproteins?. International Journal of Clinical Practice 61:11, pages 1949-1956.
Crossref
Manfredi Rizzo & Kaspar Berneis. (2006) Small, dense low‐density‐lipoproteins and the metabolic syndrome. Diabetes/Metabolism Research and Reviews 23:1, pages 14-20.
Crossref
Manfredi Rizzo & Kaspar Berneis. (2006) Low-density lipoprotein size and cardiovascular prevention. European Journal of Internal Medicine 17:2, pages 77-80.
Crossref
M. Rizzo & K. Berneis. (2006) Low-density lipoprotein size and cardiovascular risk assessment. QJM: An International Journal of Medicine 99:1, pages 1-14.
Crossref
Karin WallenfeldtLena BokemarkJohn WikstrandJohannes HultheBjörn Fagerberg. (2004) Apolipoprotein B/Apolipoprotein A-I in Relation to the Metabolic Syndrome and Change in Carotid Artery Intima-Media Thickness During 3 Years in Middle-Aged Men. Stroke 35:10, pages 2248-2252.
Crossref
B. Fagerberg, L. Bondjers & P. Nilsson. (2004) Low birth weight in combination with catch‐up growth predicts the occurrence of the metabolic syndrome in men at late middle age: the Atherosclerosis and Insulin Resistance study. Journal of Internal Medicine 256:3, pages 254-259.
Crossref
Björn Fagerberg, Lillemor Mattsson Hultén & Johannes Hulthe. (2003) Plasma ghrelin, body fat, insulin resistance, and smoking in clinically healthy men: the atherosclerosis and insulin resistance study. Metabolism 52:11, pages 1460-1463.
Crossref
Maria Leonsson, Johannes Hulthe, Jan Oscarsson, Gudmundur Johannsson, Inger Wendelhag, John Wikstrand & Bengt‐Åke Bengtsson. (2002) Intima‐media thickness in cardiovascularly asymptomatic hypopituitary adults with growth hormone deficiency: relation to body mass index, gender, and other cardiovascular risk factors. Clinical Endocrinology 57:6, pages 751-759.
Crossref
Peter Steer, Johannes Hulthe, Jonas Millgård, Dennis M. Sarabi, Samar Basu, Bengt Vessby & Lars Lind. (2002) Endothelial vasodilatory function is predicted by circulating apolipoprotein B and HDL in healthy humans. Lipids 37:12, pages 1135-1140.
Crossref
V. Sigurdardottir, B. Fagerberg & J. Hulthe. (2002) Circulating oxidized low‐density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58‐year‐old men (AIR study). Journal of Internal Medicine 252:5, pages 440-447.
Crossref
Lena BokemarkJ. WikstrandB. Fagerberg. (2016) Intact Insulin, Insulin Propeptides, and Intima-media Thickness in the Femoral Artery in 58-year-old Clinically Healthy Men. Angiology 52:4, pages 237-245.
Crossref
L. Bokemark, J. Wikstrand, S. Attvall, J. Hulthe, H. Wedel & B. Fagerberg. (2008) Insulin resistance and intima–media thickness in the carotid and femoral arteries of clinically healthy 58‐year‐old men. The Atherosclerosis and Insulin Resistance Study (AIR). Journal of Internal Medicine 249:1, pages 59-67.
Crossref
Johannes HultheLena BokemarkJohn WikstrandBjörn Fagerberg. (2000) The Metabolic Syndrome, LDL Particle Size, and Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 20:9, pages 2140-2147.
Crossref
J. Hulthe, O. Wiklund, G. Bondjers & J. Wikstrand. (2001) LDL particle size in relation to intima‐media thickness and plaque occurrence in the carotid and femoral arteries in patients with hypercholesterolaemia. Journal of Internal Medicine 248:1, pages 42-52.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.